Clinical Trials Browser

Phase 4 × Human Papillomavirus Recombinant Vaccine nonavalent × 90 days × Clear all

NCT05237947 2026-03-19

PRISMA

Phase 4 Active not recruiting

Human Papillomavirus-Related Cervical Carcinoma

NCT04206813 2026-01-27

An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen

Phase 4 Active not recruiting

Papillomavirus Infections